CoreAge Rx / Time Out
ESTRIOL 0.3% · VITAMIN C 5% · HYDROLYZED HA 0.5%
Time Out is an estriol-containing face cream, not simply a moisturizer with an anti-aging label. The current panel lists estriol 0.3%, vitamin C 5% and hydrolyzed hyaluronic acid 0.5%.
Worth buying for a specific person with a specific problem. Read who.
ASSESSED ON 0% OF THE MODEL. 6 CRITERIA LEFT UNSCORED — SEE SCORING FOR WHY.
Read the complete order, prescription and renewal terms before starting.
The verdict
CoreAge publishes a quantified active panel and a starting $48 monthly price. That makes the formula more specific than a broad hormone-skincare slogan. It still does not establish the amount absorbed from this preparation or prove its long-term safety or effectiveness.
FDA states that no drugs containing estriol are FDA-approved. Its general hormone guidance should not be treated as a trial of this face cream, and a facial application should not be assumed to eliminate hormone-related questions. The relevant history and suitability need a clinician’s assessment.
- The current product page names its intended use and headline ingredients.
- The order requires clinical review before a prescription is dispensed.
- Public marketing does not establish patient-specific suitability or finished-product results.
- Ask for the full ingredient list, exact quantity and any details not shown in the offer.
Every active, assessed
- Estriol0.3%
Hormone named on the active panel
- BENCHMARK
- Confirm the actual dispensed formula and instructions
- ASSESSMENT
- Ask why it is being considered and which history or symptoms affect suitability.
- Vitamin C5%
Brightening ingredient listed by the provider
- BENCHMARK
- Confirm the actual dispensed formula and instructions
- ASSESSMENT
- Confirm its form and the full vehicle; percentage alone is not a stability test.
- Hydrolyzed hyaluronic acid0.5%
Hydrating ingredient on the panel
- BENCHMARK
- Confirm the actual dispensed formula and instructions
- ASSESSMENT
- Hydration does not establish the effectiveness of the hormone component.
| ACTIVE | CONC. | BENCHMARK | ASSESSMENT |
|---|---|---|---|
| EstriolHormone named on the active panel | 0.3% | Confirm the actual dispensed formula and instructions | Ask why it is being considered and which history or symptoms affect suitability. |
| Vitamin CBrightening ingredient listed by the provider | 5% | Confirm the actual dispensed formula and instructions | Confirm its form and the full vehicle; percentage alone is not a stability test. |
| Hydrolyzed hyaluronic acidHydrating ingredient on the panel | 0.5% | Confirm the actual dispensed formula and instructions | Hydration does not establish the effectiveness of the hormone component. |
Scoring
- FINISHED-PRODUCT EVIDENCEWEIGHT 30%NOT ASSESSED
Ingredient background is not a controlled trial of this finished preparation.
- FORMULATION INTEGRITYWEIGHT 20%NOT ASSESSED
We have not independently tested stability, delivery or batch quality.
- DISCLOSUREWEIGHT 15%NOT ASSESSED
Published details and open questions are recorded without a numerical product score.
- TOLERANCEWEIGHT 15%NOT ASSESSED
No patient panel or clinical safety audit was conducted.
- TEXTUREWEIGHT 10%NOT ASSESSED
We did not apply or sensory-test the product.
- COST PER APPLICATIONWEIGHT 10%NOT ASSESSED
The actual prescribed amount and supply period must be established before comparison.
Open the review comparison tray →
Separate a skin concern from a hormone claim
Dryness, texture change and fine lines do not all call for the same treatment. Describe the concern and existing routine at the assessment. Ask what non-hormonal alternatives are relevant and why this particular preparation is being considered for you.
An ingredient study and a compounded finished cream are different evidence objects. Matching a concentration in a small study would not establish identical exposure, vehicle performance, participants or outcomes. This review does not turn that match into a numerical clinical endorsement.
Bring the important history to the consultation
Tell the clinician about hormone-sensitive conditions, unexplained bleeding, clotting history, pregnancy or breastfeeding plans, and other hormone treatment. The clinician should decide which issues affect the prescription. A general product review cannot clear someone to use estriol.
Ask what symptoms require contact, how use will be reassessed and who coordinates with an existing treating clinician. Do not assume a skincare consultation replaces management of menopause symptoms or a separate hormone prescription.
Read the formula and subscription separately
The active panel is useful, but request the complete ingredient list and dispensed quantity as well. Those details help identify an allergy risk and make the price comparison more meaningful. A monthly headline does not establish a measured cost per application.
Likeness’s estrogen-face-cream page is a relevant comparison because it publishes its own active panel and plan selector. Read that offer on its own terms. Similar percentages do not establish that two creams are equivalent or that either is suitable for a particular patient.
The order is not the treatment plan
Keep the chosen product, full payment and next renewal date together. A starting monthly price may describe a recurring plan or a monthly equivalent. Confirm the dispensing quantity, shipping, consultation charges and what is owed before repeating an order. A delivery estimate does not include every possible delay in clinical review or fulfillment.
CoreAge’s general policy distinguishes stopping a future subscription from refunding an order already approved and transmitted to a pharmacy. It describes possible non-refundable consultation fees and a separate 30-day cutoff. Read the terms attached to the selected skincare order and resolve any different checkout promise before paying.
How this record was prepared
We read public product and policy pages on October 5, 2026 and checked the ingredient context against the sources below. We did not order the cream, inspect a pharmacy batch, interview a treating clinician or test it on a patient panel. Product directions can change; the label and clinician’s instructions for the dispensed prescription take priority over a general review.
This is a public-source assessment. Unmeasured clinical results, texture and tolerance are not converted into a product score. Our featured-provider order is a separate publisher preference, described in the disclosure. It is not a clinical ranking of these formulas.
Who this is for
- You want to discuss this particular formula with a clinician.
- You can compare the full payment and follow-up arrangement before ordering.
- You have not resolved relevant allergies, pregnancy plans or medical-history questions with the clinician.
- You need an assessment of a new, changing or undiagnosed skin lesion.
Read the complete order, prescription and renewal terms before starting.
This is an editorial assessment of published information about aprescription product. It is not a diagnosis, not a prescription and not a substitute for your own prescriber. Hydroquinone and tretinoin are drugs. Decisions about them belong with a clinician who has seen your skin.
Sources
- S-01CoreAge Rx — Time Out Public source checked October 5, 2026. Provider descriptions are not independent product testing.
- S-02FDA — menopause and hormone questions FDA states that there are no FDA-approved drugs containing estriol. Its general hormone discussion does not quantify absorption from this particular face cream. Checked October 5, 2026.
- S-03CoreAge Rx — payment, subscription and refund policy Public source checked October 5, 2026. Provider descriptions are not independent product testing.
- S-04FDA — compounding questions and answers Medical or regulatory context checked October 5, 2026; not a study of the reviewed finished product.